1. Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. • Generate individualized risk for anti thrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
2. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm. D.
1. Nice.